¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ë±¸°¡Å縯´ëÇб³º´¿ø ¸Á¸· : 2020-02-29

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ë±¸°¡Å縯´ëÇб³º´¿ø ¸Á¸· : 2020-02-29
±³À°ÀÏÀÚ : 2020-02-29
±³À°Àå¼Ò : ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ  
±³À°ÁÖÁ¦ : ¸Á¸·
ÁÖÃÖ±â°ü : ´ë±¸°¡Å縯´ëÇб³º´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¾È°ú  
´ã´çÀÚ : À̽ÃÀº
¿¬¶ôó : 053-650-4728  
À̸ÞÀÏ : dcmc_ot@naver.com      
±³À°Á¾·ù : ¾È°ú      
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ´ë±¸±¤¿ª½Ã
±³À°½Ã°£ : 6 ½Ã°£ 10ºÐ  
¼¼ºÎ¼ö°­·á : 60,000¿ø      
ºñ°í »çÀüµî·Ï- Àü¹®ÀÇ 50,000¿ø, Àü°øÀÇ 40,000¿ø ÇöÀåµî·Ï- Àü¹®ÀÇ 60,000¿ø, Àü°øÀÇ 50,000¿ø °èÁ¹øÈ£ 508-13-827509-5(´ë±¸ÀºÇà, ¹é¹ÎÁÖ)      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 09:20~09:30 Multimodal imaging of type 1,2,3 CNV  Á¤Àοµ(°æ»óÀÇ´ë) 
±³À°½Ã°£ 02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 09:30~09:40 Clinical application of OCTA in ARMD and its allied disease  ÀÌÁÖ¿ë(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 09:40~09:50 Clinical application of OCTA in DMR and BRVO  ¹Úµ¿È£(°æºÏÀÇ´ë) 
±³À°½Ã°£ 02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 09:50~10:00 Clinical value of wide FP and FA and ICG  »ç°ø¹Î(¿µ³²ÀÇ´ë) 
±³À°½Ã°£ 02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 10:00~10:10 Enface OCT imaging  ¾È¼ºÁØ(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 10:10~10:20 AF imaging in retinal field  À¯½Â¿µ(°æÈñÀÇ´ë) 
±³À°½Ã°£ 02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 10:20~10:30 Imaging of choroid  ¹Ú¼ºÇ¥(ÇѸ²ÀÇ´ë) 
Åä·Ð 02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 10:30~10:45 DIscussion  () 
È޽Ġ02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 10:45~11:05 Break  () 
±³À°½Ã°£ 02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 11:05~11:15 Classification of various drusen  ±èÀ¯Ã¶(°è¸íÀÇ´ë) 
±³À°½Ã°£ 02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 11:15~11:25 Dry ARMD treatment, present and emerging  ±èÇö¿õ(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 11:25~11:35 Risk factor of geographic atrophy secondary to ARMD  ÃÖ°æ½Ä(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 11:35~11:45 Update of pachychoroid diseases  ÀÌ¿ø±â(´©³×¾È°úº´¿ø) 
±³À°½Ã°£ 02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 11:45~11:55 Treatment of wet ARMD and PCV, experience and future  °íÇüÁØ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 11:55~12:05 Myopic CNV, treatment and DDX  ½ÅÀçÇÊ(°æºÏÀÇ´ë) 
±³À°½Ã°£ 02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 12:05~12:15 Mactel type 2 current concept  ¿ÀÀç·É(°í·ÁÀÇ´ë) 
Åä·Ð 02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 12:15~12:30 DIscussion  () 
½Ä»ç 02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 12:30~13:30 Lunch time  () 
±³À°½Ã°£ 02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 13:30~14:00 ±è½Ãµ¿ ±³¼ö ¼Ò°³ ¹× Ưº° °­¿¬  ±è½Ãµ¿(´ë±¸°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 14:00~14:10 Lessons from DRCR.net protocol I, S, T  ¼ÛÁöÈÆ(¾ÆÁÖÀÇ´ë) 
±³À°½Ã°£ 02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 14:10~14:20 Brief summary of ongoing DRCR.net protocol U, V, W  À̽¿ì(µ¿±¹ÀÇ´ë) 
±³À°½Ã°£ 02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 14:20~14:30 Anti VEGF in DME  Á¶¿µÁØ(Ãæ³²ÀÇ´ë) 
±³À°½Ã°£ 02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 14:30~14:40 Steroid role in DME  ÀÌÁ¾Çö(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 14:40~14:50 Managenet of refractory DME and DMR progression in real practice  ÁøÈñ½Â(ÀÎÇÏÀÇ´ë) 
±³À°½Ã°£ 02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 14:50~15:00 Endophthalmitis after intravitreal injection  ¹Ú¿µÈÆ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 15:00~15:10 Current management of vein occlusion  ³²µ¿Èç(°¡ÃµÀÇ´ë) 
Åä·Ð 02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 15:10~15:25 Discussion  () 
È޽Ġ02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 15:25~15:40 Break  () 
±³À°½Ã°£ 02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 15:40~15:50 Vitrectomy for RRD(case slection, tamponade, etc)  ±èö±¸(±è¾È°úº´¿ø) 
±³À°½Ã°£ 02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 15:50~16:00 Vitrectomy for ERM(good vision caes, inner lamellar hole)  ±èÀ±¿µ(´ë±¸°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 16:00~16:10 Vitrectomy for IOL dislocation(various method)  ±è¼º¼ö(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 16:10~16:20 Vitrectomy for macular hole(conventional/flap, prone, tmponade, etc)  ÀÌÁöÀº(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 16:20~16:30 Vitrectomy for uveitis(what cases, combine treatment, etc)  À¯Çü°ï(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 16:30~16:40 Vitrectomy for DMR(how to improve result, adjuvant, etc)  ±èÁß°ï(¼­¿ï¾Æ»êº´¿ø) 
±³À°½Ã°£ 02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 16:40~16:50 3D surgery(merits and limitation)  ¹Ú±ÔÇü(¼­¿ïÀÇ´ë) 
Åä·Ð 02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 16:50~17:05 Discussion  () 
±âŸ 02-29 ´ë±¸°¡Å縯´ëÇб³º´¿ø µ¥·¹»ç°ü 3Ãþ µ¥·¹»çȦ 17:05~17:10 Closing  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ë±¸°¡Å縯´ëÇб³º´¿ø ¸Á¸· : 2020-02-29""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦12ȸ °Ç°­º¸Çè ºòµ¥ÀÌÅÍ ÀÚ·áºÐ¼®À» ÅëÇÑ ³í¹®Ãâ°£ ¿öÅ©¼¥ : 2020-02-29
´ÙÀ½±Û Á¦ 6ȸ Á¶Ç÷¸ð¼¼Æ÷ÀÌ½Ä ¾ÆÄ«µ¥¹Ì: 2020-02-29
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
345 ÀüºÏ ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ ÀÎÁöÁßÀçÄ¡·áÀÇ ½ÇÁ¦¿Í Àü¸Á : 2018-09-04 0 556 2018-08-08
344 ºÎ»ê ºÎ¿ï°æ³»ºÐºñ´ë»çÇÐȸ 9¿ù Á¤±âÁý´ãȸ : 2018-09-04 0 516 2018-08-08
343 ¼­¿ï Á¦42ȸ ÇѸ²´ëÇб³°­³²¼º½Éº´¿ø ¾È°ú Áý´ãȸ : 2018-09-03 0 880 2018-08-08
342 ¼­¿ï ¼øõÇâ´ëÇм­¿ïº´¿ø Á¦42ȸ º¹ºÎÃÊÀ½ÆÄ ¹× ³»½Ã°æÃÊÀ½ÆÄ Áø´Ü ¿öÅ©¼ó : 2018-09-02 0 949 2018-08-08
341 ºÎ»ê Á¦21ȸ ´ëÇѳ»°úÇÐȸ ºÎ»ê°æ³²Áöȸ ¿¬¼ö°­Á : 2018-09-02 0 870 2018-08-08
340 ¼­¿ï 2018 ¼Ò¾Æ³»ºÐºñÇÐȸ ¿¬¼ö°­Á : 2018-09-02 0 1,198 2018-08-08
339 ´ëÀü ´ëÇѳëÀÎÁ¤½ÅÀÇÇÐȸ Á¦10ȸ Ä¡¸ÅÁø·áÀÇ»ç Àü¹®È­±³À° (part4, 2ÀÏÂ÷) : 2018-09-02 0 611 2018-08-08
338 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø Á¦23ȸ ´ç´¢º´ÀÇ ¿À´Ã°ú ³»ÀÏ : 2018-09-02 0 1,421 2018-08-08
337 ¼­¿ï ´ëÇÑû°¢ÇÐȸ 2018 Á¦19Â÷ º¸Ã»±â¿öÅ©¼¥ : 2018-09-02 0 730 2018-08-08
336 ºÎ»ê 2018³â ´ëÇѹ̼¼¼ö¼úÇÐȸ Ãß°è Microsurgery Workshop : 2018-09-02 0 1,061 2018-08-08
335 ´ëÀü ´ëÇÑÀÓ»ó½Å°æ»ý¸®ÇÐȸ Á¦4ȸ ã¾Æ°¡´Â ¿öÅ©¼ó : 2018-09-02 0 1,029 2018-08-08
334 ´ë±¸ ´ë±¸±¤¿ª½ÃÀÇ»çȸ 2018 Á¾ÇÕÇмú´ëȸ : 2018-09-02 0 756 2018-08-08
333 ¼­¿ï 2018³â ´ëÇÑ¿Ü°úÀÇ»çȸ Ã߰迬¼ö°­Á : 2018-09-02 1 3,027 2018-08-08
332 ´ëÀü ´ëÇѳëÀÎÁ¤½ÅÀÇÇÐȸ Á¦10ȸ Ä¡¸ÅÁø·áÀÇ»ç Àü¹®È­±³À° (part4,1ÀÏÂ÷) : 2018-09-01 0 435 2018-08-08
331 ´ëÀü ´ëÇѳëÀÎÁ¤½ÅÀÇÇÐȸ Á¦10ȸ Ä¡¸ÅÁø·áÀÇ»ç Àü¹®È­±³À° (part4,1ÀÏÂ÷) : 2018-09-01 0 1,007 2018-08-08
1381 | 1382 | 1383 | 1384 | 1385 | 1386 | 1387 | 1388 | 1389 | 1390
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷